Status: Recruiting
Liver Adiposity Effects on Pediatric Statin
Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin
Participants needed: 50
Trial details
Phase: Phase 1Age: 8-21Biological sex: AllType: InterventionalSponsor: Children's Mercy Hospital Kansas CityUpdated: Jun 25, 2026Locations: 1
Eligibility criteria
8-21 years [+5]
Pregnancy [+10]